{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T09:15:18Z","timestamp":1781428518631,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejca.2022.06.054","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T18:09:04Z","timestamp":1660932544000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Reporting of melanoma cell densities in the sentinel node refines outcome prediction"],"prefix":"10.1016","volume":"174","author":[{"given":"Anja","family":"Ulmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pfefferle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-1161","authenticated-orcid":false,"given":"Vincent","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Granai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Keim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-293X","authenticated-orcid":false,"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Sulyok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"B\u00f6sm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.06.054_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001604","article-title":"Quantitative measurement of melanoma spread in sentinel lymph nodes and survival","volume":"11","author":"Ulmer","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.06.054_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib7","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.06.054_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CMR.0000000000000643","article-title":"External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?","volume":"30","author":"Madu","year":"2020","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2022.06.054_bib9","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.06.054_bib10","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final analysis of DeCOG-SLT trial: No survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node","volume":"37","author":"Leiter","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.06.054_bib11","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2022.06.054_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.12.002","article-title":"The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival","volume":"91","author":"Ulmer","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.06.054_bib13","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1158\/1078-0432.CCR-04-1995","article-title":"Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes","volume":"11","author":"Ulmer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.06.054_bib14","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.06.054_bib15","series-title":"R: a language and environment for statistical computing","year":"2019"},{"key":"10.1016\/j.ejca.2022.06.054_bib16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1245\/s10434-011-2208-z","article-title":"Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative","volume":"19","author":"Murali","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.06.054_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejca.2011.08.019","article-title":"Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study","volume":"48","author":"Riber-Hansen","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.06.054_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/00000478-200309000-00002","article-title":"Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy","volume":"27","author":"Li","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2022.06.054_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.03.010","article-title":"An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma","volume":"114","author":"Cook","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.06.054_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0b013e3181c70ee8","article-title":"Location of melanoma metastases in sentinel lymph nodes: what are the implications for histologic processing of sentinel lymph nodes in routine practice?","volume":"34","author":"Murali","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2022.06.054_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/apm.12240","article-title":"Nodal distribution, stage migration due to diameter measurement and the prognostic significance of metastasis volume in melanoma sentinel lymph nodes: a validation study","volume":"122","author":"Riber-Hansen","year":"2014","journal-title":"Apmis"},{"key":"10.1016\/j.ejca.2022.06.054_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/PAS.0000000000001229","article-title":"Small and isolated immunohistochemistry-positive cells in melanoma sentinel lymph nodes are associated with disease-specific and recurrence-free survival comparable to that of sentinel lymph nodes negative for melanoma","volume":"43","author":"LeBlanc","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2022.06.054_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO;2-W","article-title":"Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in\u00a0vivo","volume":"75","author":"Cormier","year":"1998","journal-title":"Int J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922004063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922004063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:37:22Z","timestamp":1760733442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922004063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"alternative-id":["S0959804922004063"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.06.054","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reporting of melanoma cell densities in the sentinel node refines outcome prediction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.06.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}